BioLife Solutions, Inc. (BLFS)
| Market Cap | 1.96B |
| Revenue (ttm) | 74.06M |
| Net Income (ttm) | 3.54M |
| Shares Out | 38.07M |
| EPS (ttm) | 0.11 |
| PE Ratio | 416.58 |
| Forward PE | 2,500.00 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,119,369 |
| Open | 46.00 |
| Previous Close | 45.99 |
| Day's Range | 45.08 - 47.97 |
| 52-Week Range | 24.56 - 60.67 |
| Beta | 1.41 |
| Analysts | Buy |
| Price Target | 62.14 (+30.8%) |
| Est. Earnings Date | Nov 4, 2021 |
About BLFS
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line ...
Financial Performance
Financial StatementsAnalyst Forecast
According to 9 analysts, the average rating for BLFS stock is "Buy." The 12-month stock price forecast is 62.14, which is an increase of 30.85% from the latest price.
News
BioLife Solutions Announces CFO Retirement
BOTHELL, Wash., Sept. 15, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services...
Why Shares in BioLife Solutions Jumped 24.4% in August
The company, which specializes in cold-storage solutions for biotechs, had a hot month.
BioLife Solutions Files Form S-3 Registration Statement to Register Shares from Completed Acquisitions
BOTHELL, Wash., Sept. 1, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services...
BioLife Solutions Closes Acquisition of Sexton Biotechnologies
BOTHELL, Wash., Sept. 1, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services...
2 Little-Known Nasdaq Stocks Making Big Moves Wednesday
Don't let these companies fly under your radar.
BioLife Solutions Joins S&P SmallCap 600 Index
BOTHELL, Wash., Aug. 25, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and service...
BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Top Estimates
BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of 480.00% and 10.19%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: BioLife Solutions Q2 Earnings
Shares of BioLife Solutions (NASDAQ:BLFS) moved higher by 4.2% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 100.00% over the past year to (...
BioLife Solutions Announces Second Quarter 2021 Financial Results
BOTHELL, Wash., Aug. 12, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and service...
Sexton Biotechnologies to be Acquired by Biolife Solutions
INDIANAPOLIS, Aug. 9, 2021 /PRNewswire/ -- Sexton Biotechnologies, a provider of novel manufacturing solutions for the cell and gene therapy (CGT) industry, today announced that it has entered into a de...
BioLife Solutions to Acquire Sexton Biotechnologies to Expand Cell and Gene Therapy Tools Portfolio
BOTHELL, Wash., Aug. 9, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services...
BioLife Solutions to Report Second Quarter 2021 Financial Results and Provide Business Update on August 12, 2021
BOTHELL, Wash., Aug. 5, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction produc...
BioLife Solutions, Inc. (BLFS) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
BioLife Solutions, Inc. (BLFS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BioLife Solutions Announces Changes to Board of Directors
BOTHELL, Wash., July 14, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and service...
BioLife Solutions Adopts New Brand Identity
BOTHELL, Wash., June 15, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and service...
BioLife Solutions Announces Promotion of Caitlin Rice to Global Vice President, Customer Service
BOTHELL, Wash., May 19, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services...
BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Tops Revenue Estimates
BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of 40.00% and 8.01%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
BioLife Solutions to Report First Quarter 2021 Financial Results and Provide Business Update on May 13, 2021
BOTHELL, Wash., May 6, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction product...
Earnings Preview: BioLife Solutions, Inc. (BLFS) Q1 Earnings Expected to Decline
BioLife Solutions, Inc. (BLFS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BioLife Solutions Announces Closing of Stirling Ultracold Acquisition and Expanded Partnership with Leading Global Bi...
BOTHELL, Wash., May 3, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction products...
BioLife Solutions Launches New High Capacity Controlled Rate Freezer Line with First Shipment to a Leading Cell Thera...
BOTHELL, Wash., April 15, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction produc...
HRC or BLFS: Which Is the Better Value Stock Right Now?
HRC vs. BLFS: Which Stock Is the Better Value Option?
BioLife Solutions Appoints Two New Independent Board Directors
BOTHELL, Wash., April 6, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction produ...
HRC vs. BLFS: Which Stock Is the Better Value Option?
HRC vs. BLFS: Which Stock Is the Better Value Option?
BioLife Solutions, Inc. (BLFS) Reports Q4 Loss, Tops Revenue Estimates
BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of 0.00% and 9.67%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?